| Pharmaceutical Formulations | Specialty pharmaceutical products focusing on pain management and chronic conditions. | WHO-GMP compliant manufacturing, strong regulatory credentials, extensive distribution network, and focused R&D. | B2B clients include hospitals, government bodies; B2C through pharmacies and OTC sales. | Specialty formulations and OTC wellness products. | 15169 | 100 | Product sales to pharmacies, healthcare institutions, and government entities. | Direct sales with standard industry pricing; competitive and regulated pricing models. | Innovation, digital engagement, regulatory approvals, and expanding product portfolio. | Powergesic 4X, Zixflam Forte, Nervijen D3 |
| Exports | Pharma products supplied to 13 international markets. | Global regulatory approvals and compliance, established export channels. | Pharmaceutical wholesalers and distributors internationally. | Regulated markets with premium pricing potential. | 1904 | 13 | Export sales through distributors and direct partners. | Contractual agreements and export pricing frameworks. | Global demand, 'China+1' strategy, regulatory approvals in export markets. | Pharmaceutical formulations exported globally |
